AZEK Co (NYSE:AZEK) Stock

AZEK Co

The AZEK Co Inc is a designer and manufacturer of beautiful, low maintenance and environmentally sustainable products focused on the fast-growing Outdoor Living market. Its portfolio of products includes decks, rail, trim, outdoor furniture among others. The company operates in two segments: Residential Segment that manufactures and distributes decking, railing, trim, moulding, pergolas and cabanas and accessories through a national network of dealers and distributors and multiple home improvement retailers; and Commercial Segment that manufactures, fabricates and distributes lockers and bathroom partitions. It generates maximum revenue from the Residential segment. The company's brand includes TimberTech; AZEK; Versatex, Ultralox, StruXure, and Intex.

The AZEK Company Inc. Class A Common Stock

The AZEK Co Inc

Goodfire, an ambitious AI startup launched by seasoned entrepreneur Eric Ho, <a href="https://www.benzinga.com/25/04/44833198/can-ai-talk-to-dolphins-googles-deepmind-creates-dolphingemma-to-explore-animal-language">DeepMind</a> alumnus Thomas McGrath, and Daniel Balsam, a founding engineer at RippleMatch, just raised a $50 million Series A round led by Menlo Ventures, with participation from Anthropic, Lightspeed Venture Partners, B Capital, Work-Bench, Wing, and South Park Commons.
The company is building Ember, an interpretability platform designed to expose and reprogram the internal logic of advanced <a href="https://www.benzinga.com/markets/25/04/44661561/mark-zuckerbergs-meta-unveils-latest-llama-4-ai-models-to-challenge-openais-chatgpt-4-and-googles-gemini">AI models</a>. Rather than relying on input/output behavior or prompt engineering, Ember gives developers direct, programmable access to what's actually happening inside the model's neural networks, according to<a href="https://www.goodfire.ai/blog/announcing-our-50m-series-a"> Goodfire</a>.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
</ul>
<h2 class="wp-block-heading">Goodfire Is Breaking Open the Black Box</h2>
AI models are often referred to as &#8220;black boxes&#8221; due to their complex and opaque decision-making processes. Goodfire aims to change that narrative by developing tools that allow developers to peer inside these models, understand their reasoning, and guide their behavior toward safer and more reliable outcomes.
Founded in 2024 and based in San Francisco, Goodfire is positioning itself as a foundational player in mechanistic interpretability, a rapidly growing field aimed at making AI less of a black box and more of a controllable system, writes <a href="https://techstartups.com/2025/04/18/anthropic-backs-goodfire-in-50m-series-a-to-decode-ai-models-marking-first-ever-startup-investment/">Tech Startups</a>.
Goodfire&#8217;s team comprises some of the most respected names in AI research. According to <a href="https://www.fastcompany.com/91320043/this-startup-wants-to-reprogram-the-mind-of-ai-and-just-got-50-million-to-do-it">Fast Company</a>, Lee Sharkey is known for his work on sparse autoencoders in language models, while Nick Cammarata, another team member, started the interpretability team at OpenAI alongside Chris Olah, who later co-founded Anthropic.
Trending: Donald Trump Just Announced a $500 Billion AI Infrastructure Deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">Here's How You Can Invest in the Entertainment Market's Next Big Disruptor for Just $998</a>
According to <a href="https://techstartups.com/2025/04/18/anthropic-backs-goodfire-in-50m-series-a-to-decode-ai-models-marking-first-ever-startup-investment/">Tech Startups</a>, Anthropic, the AI safety-focused startup behind the Claude chatbot, made its first-ever startup investment by contributing $1 million to Goodfire&#8217;s Series A round. This investment signals growing industry consensus that tools enabling transparency and control are critical infrastructure for the next generation of AI.
<h2 class="wp-block-heading">Goodfire&#8217;s Vision</h2>
Eric Ho, co-founder and CEO of Goodfire, emphasized the significance of their work in the startup&#8217;s funding<a href="https://www.goodfire.ai/blog/announcing-our-50m-series-a"> announcement</a>: &#8220;Nobody understands the mechanisms by which AI models fail, so no one knows how to fix them. Our vision is to build tools to make neural networks easy to understand, design, and fix from the inside out. This technology is critical for building the next frontier of safe and powerful foundation models.&#8221;
According to <a href="https://fastcompanyme.com/technology/this-startup-wants-to-reprogram-the-mind-of-ai-and-just-got-50-million-to-do-it/">Fast Company</a>, Goodfire has started receiving interest from Fortune 500 companies looking to understand and influence how their AI models &#8220;think&#8221; since many still treat these systems like traditional software, expecting reprogrammable logic where none exists, explained Eric Ho. Language models respond with probability, not precision, and reshaping their behavior means diving deep into how they reason. Goodfire's tools offer companies a first step toward that kind of control, even if the science is still in its early stages.
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Goodfire&#8217;s Ember platform is already being utilized by organizations like the Arc Institute to extract novel biological concepts from their DNA foundation model, Evo 2. This collaboration has enabled scientists to uncover insights that were previously hidden within the model&#8217;s complex structure.
<h2 class="wp-block-heading">The Road Ahead</h2>
With the new funding, Goodfire plans to expand its research initiatives and enhance the Ember platform. The goal is to make AI systems more transparent, controllable, and aligned with human values.
As AI continues to permeate various aspects of society, tools like Ember will be instrumental in ensuring that these systems operate safely and effectively.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Image: Shutterstock

News

Goodfire Lands $50M From Anthropic & Silicon Valley Giants To Open The Black Box Of AI — Before It Rewrites Us First

Kevin O'Leary isn't just managing portfolios—he's managing his health like an asset. In a recent <a href="https://www.instagram.com/kevinolearytv/reel/DIgj0M8idfQ/?locale=slot%2Bgacor%2Bdemo%E3%80%90GB77.CC%E3%80%91.sjaz&amp;hl=en">Instagram post</a>, the "Shark Tank" investor shared his no-cost wellness routine, calling it a crucial part of his success strategy.
&nbsp;"Watch what you eat&#8230; that's an easy hack," he said, urging others to see health as a long-term investment. O'Leary, who lives part-time in Miami, revealed how daily fitness, clean eating, and avoiding harmful habits keep his body—and business mind—on track.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
<h2 class="wp-block-heading">Treat Your Body Like A Business</h2>
O'Leary&#8217;s routine starts with a 12-mile bike ride through the Miami streets, followed by strength training and stretching.&nbsp;
He spends about 90 minutes each day on his wellness regimen. "You've got to exercise every day," O'Leary said in the video. "What I like to do&#8230; is take my bike out for a 12-mile ride every day and then do some weights, a little stretching."
According to O'Leary, the key to career longevity is physical and mental wellness. He compared personal health to managing a financial portfolio, saying that taking care of your body has&nbsp;
dire complications for productivity.&nbsp;
"You know, you invest in so many things as an investor, but you also have to invest in yourself—physical fitness and longevity," he said.&nbsp;
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">Backed By Science</h2>
O'Leary's fitness claims align with current research. A review published in March in the <a href="https://bjsm.bmj.com/content/early/2025/03/06/bjsports-2024-108589">British Journal of Sports Medicine </a>found that even light-intensity exercise improves memory and executive function across all age groups.&nbsp;
The<a href="https://www.cdc.gov/physical-activity/features/boost-brain-health.html"> Centers for Disease Control and Prevention</a> also supports this, stating that regular physical activity boosts brain health and may reduce dementia risk.
<h2 class="wp-block-heading">Nutrition Is the Real MVP</h2>
In his Instagram post, O'Leary also emphasized mindful eating as a foundation for energy and focus. "Do not overeat, and really watch what you eat&#8230; you feel great, and you're helping your body," he said.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Small behavioral changes—such as mindful eating and self-monitoring—can significantly improve both physical and mental health, <a href="https://onlinelibrary.wiley.com/doi/10.1111/obr.13150">according to a study</a> co-authored by Dr. Amy Ahern of the University of Cambridge's MRC Epidemiology Unit. These findings support O'Leary's claim that simple actions can yield outsized benefits.
<h2 class="wp-block-heading">Skip the Vices</h2>
O'Leary also warned about behaviors that could sabotage success: binge drinking, smoking, and drug use. "Watch how much you drink. Don't do a lot of drugs, that's bad for you," he said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Kevin O'Leary Shares His $0 Wellness Secret – 'Watch What You Eat... That's An Easy Hack' For Success

<ul>
<li>Neurotechnology company Neuralink is expected to get an $8.5 billion pre-money valuation </li>
<li>Insiders say that an upcoming funding round for the Elon Musk venture is likely to raise $500 million</li>
<li>The company, which was founded in 2016, has successfully implanted its brain-computer interfaces in three individuals </li>
</ul>
Elon Musk's Neuralink Corp. is planning to raise $500 million at an upcoming funding round, giving it a pre-money valuation of $8.5 billion, <a href="https://www.bloomberg.com/news/articles/2025-04-23/musk-s-neuralink-said-to-eye-fundraise-at-8-5-billion-valuation">Bloomberg</a> reported Wednesday.
The insiders who spoke to the outlet clarified that the company was still in preliminary discussions with potential investors, and that the terms of the funding rounds have yet to be finalized, meaning that the valuation could change before all is said and done.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
</ul>
Founded in 2016, Neuralink is a neurotechnology company that aims to develop implantable brain-computer interfaces, or BCI. When it was first publicized in 2017, Musk said that he hoped to have the first chips implanted in people within eight to 10 years.
In early 2024, that goal was achieved when Neuralink implanted the world's first BCI into a man named Noland Arbaugh. The quadraplegic has been able to use the device, which is controlled by his thoughts, to access the internet, post on social media, and play games like chess.
Earlier this year, Musk said that two more people had received implants. Following the successful operations, the company reportedly hopes to complete an additional 20 to 30 implants before the year is out.
Trending: Donald Trump Just Announced a $500 Billion AI Infrastructure Deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">Here's How You Can Invest in the Entertainment Market's Next Big Disruptor for Just $998</a>
Initially, the Food and Drug Administration&nbsp; rejected Neuralink's request to begin human trials, citing safety concerns. Specifically, the agency was concerned about the implants' lithium batteries and the possibility of wires migrating to other parts of the brain. But eventually, that decision was reversed, and the BCIs have been in clinical trials since 2022.
Thus far, the devices have all been implanted in individuals living with quadriplegia and are being considered for those who experience blindness. Though Musk has said he has no intention of stopping there. He's spoken at length about the potential for Neuralink BCIs in connecting the human brain with AI, an option he'd like to see available to able-bodied consumers as well.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
Neuralink is not the only company working on BCIs, either. According to the federal government's<a href="https://clinicaltrials.gov/search?cond=brain%20computer%20interface&amp;aggFilters=status:not%20rec%20act&amp;viewType=Table"> database of clinical studies</a>, there are currently more than 45 trials involving brain-computer interfaces.&nbsp;
Marco Baptistal, the chief scientific officer of the Christopher &amp; Dana Reeve Foundation, told the <a href="https://apnews.com/article/elon-musk-neuralink-brain-computer-interface-9dbc92206389f27fd032825cf1597ee5">Associated Press</a> that the new technology is "very exciting" and that through clinical trials, like the ones at Neuralink, "we'll be able to see what's going to be the winning approach." Baptistal continued, "We need to really support high-risk, high-reward endeavors. This is clearly high-risk, high-reward. We don't know how safe it's going to be. We don't know how feasible it's going to be."
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

Elon Musk's Neuralink Expected To Get $8.5 Billion Valuation

<ul>
<li>Tariffs on women's clothing are currently 3% higher than those on men's clothing, costing female consumers $2 billion more annually </li>
<li>President Trump's new tariff policies are expected to widen that gap, hitting women's pockets harder than men's</li>
<li>Earlier this year, legislators introduced the Pink Tariffs Study Act, which would force agencies to look at how these gendered policies impact consumers</li>
</ul>
President Donald Trump's tariffs are sending shockwaves through the economy, threatening to increase the cost of everything from generic drugs to auto parts. Now there's yet another sector where experts are warning consumers will likely see a dramatic increase in cost: women's clothing.
For years, tariffs have been higher on imported women's clothing than on men's. According to research done by the <a href="https://www.progressivepolicy.org/ppis-trade-fact-of-the-week-u-s-clothing-tariffs-are-unfair-to-women/">Progressive Policy Institute</a>, a left-leaning think tank, tariffs on women's clothing are consistently 3% higher than those on men's. Known as "pink tariffs," these taxes mean women typically pay $1 more per garment than men. Over the course of a year, that adds up to a $2 billion difference in spending.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>
The U.S. Harmonized Tariff Schedule, which divides imported goods into 11,414 lines, typically classifies clothing and footwear imports by gender. In 2022, tariffs on women's items stood at 16.7%, while men's items only faced a 13.6% levy. The few genderless items that sneak through are only subject to a 12% tariff rate.
There's no singular reason for this difference in rate; rather, it&#8217;s a policy that has taken shape over decades.
According to <a href="https://www.cnn.com/2025/04/16/business/womens-clothes-pink-tariffs/index.html">CNN</a>, during the 1930s and 1940s, when the global free trading system was just getting started, men's clothing was a much bigger industry than women's clothing. Because it provided far more employment and played a bigger role in our economy, American textile and apparel manufacturers were much more focused on lowering tariffs and ending trade barriers in this sector. Today's tariff gap is a relic of that old battle.
Modern companies have attempted to rectify this gender bias, but have had little luck. In 2007,&nbsp; several companies, including Steve Madden, Asics, and Columbia Sportswear, sued to have the policy struck down. The companies lost the case after it was ruled that the tariffs were not designed to be discriminatory.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
But tides may finally be turning. Earlier this year, two members of Congress, Democratic Reps. Lizzie Fletcher of Texas and Brittany Petersen of Colorado introduced the <a href="https://fletcher.house.gov/uploadedfiles/pink_tariffs_study_act-119th.pdf">Pink Tariffs Study Act</a>, which would require several government agencies to examine the impact of the gendered tariffs on women and other consumer groups.
For now, though, experts say these increased tariffs on many of the country's closest trading partners will impact women more than men, if for no other reason than women spend more on clothes per year than men. According to data from the <a href="https://www.bls.gov/opub/ted/2025/apparel-data-in-fashion.htm">U.S. Bureau of Labor Statistics</a>, in 2023, average household spending on women's clothing was $655 compared to $406 for men.
"As he is instituting massive new tariffs, President Trump is missing a chance to tackle historically regressive and misogynistic traits [of the global free trade system]," Steve Lamar, president of the American Apparel &amp; Footwear Association, told CNN.&nbsp;
Lori Taylor, a professor at Texas A&amp;M agreed, telling the outlet, "My policy preference would have been to lower tariffs for both men's and women's clothing" in order to reduce the gap.
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
Image: Shutterstock

Pink Tariffs Cost Women $2 Billion More Than Men, And The Gap Could Widen

Oppenheimer analyst Scott Schneeberger maintains Pool (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>) with a Outperform and lowers the price target from $370 to $322.

Price Target

Analyst Ratings

POOL

Oppenheimer Maintains Outperform on Pool, Lowers Price Target to $322

<a href="http://www.sapiens.com/?_gl=1&#x2A;r0e4u4&#x2A;_gcl_au&#x2A;ODg2NTc3MDc2LjE3NDIyMDM2MDk.&#x2A;_ga&#x2A;MjA2ODc0OTY5My4xNzE4ODAwNDc5&#x2A;_ga_2ZQ5FTGERQ&#x2A;MTc0MjcxMjg2OC4yNDAuMS4xNzQyNzEyODc3LjUxLjAuMA..">Sapiens International Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that&nbsp;it has signed a definitive agreement for the acquisition of AdvantageGo, a leading commercial insurance software provider specializing in underwriting workbench solutions for both London and global commercial markets. This strategic acquisition significantly enhances Sapiens' global P&amp;C proposition, adding cutting-edge underwriting workbench capabilities that address one of the most critical challenges in the P&amp;C industry today: managing, assessing, and writing risk more effectively.
For the full year 2024, AdvantageGo revenues were 15 million British pounds, based on US GAAP, with approximately 50% from recurring revenues, with Gross margin, accretive to Sapiens Gross Margin.
AdvantageGo has made significant strategic investments in its product in recent years. As a result, of these strategic growth investments the company reported a loss of 9 million British pounds in full year 2024. As Sapiens integrates AdvantageGo's offerings into the broader portfolio and continues to support its market penetration, we expect AdvantageGo to grow at double-digit rate in 2026. AdvantageGo profitability is expected to improve over time, and become accretive to Sapiens' profit starting in 2027, driven by revenue growth and integration synergies with Sapiens.
The transaction is expected to be consummated in the coming weeks. Upon completion, Advantage Go will become wholly owned by Sapiens. The acquisition of Advantage Go is structured as a&nbsp;cash deal, based on an enterprise value of 43 million British pounds.&nbsp;

SPNS

Sapiens International Agrees To Acquire AdvantageGo For Enterprise Value Of GBP 43M

The Atlantic published an in-depth <a href="https://www.theatlantic.com/magazine/archive/2025/06/trump-second-term-comeback/682573/">interview</a> with President Donald Trump on Monday, marking the first 100 days of his second term<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45034627/us-stock-futures-fall-as-markets-brace-for-earnings-from-microsoft-meta-apple-and-apple-this-week-earnings-estimates-dont-signal-a-recession-says-leading-analyst"> in the White House.&nbsp;</a>
What To Know: The president sat down in the Oval Office with journalists Ashley Parker and Michael Scherer from The Atlantic and the publication's editor-in-chief, Jeffrey Goldberg.&nbsp;
The interview followed a period of public tension after Goldberg had been accidentally added to a Signal <a href="https://www.benzinga.com/news/25/04/44890554/there-is-complete-meltdown-in-the-building-defense-secretary-loses-four-key-staffers-in-a-single-day">group chat</a> involving senior Trump officials and classified discussions and then publicly revealed the security breach in a published article. 
Read Next: <a href="https://www.benzinga.com/25/04/45012792/trump-administration-to-resume-collections-on-student-loans-5-million-borrowers-in-default?utm_source=articleShare">Trump Administration To Resume Collections On Student Loans: 5 Million Borrowers In Default&nbsp;</a>
In the weeks before the interview, Trump posted several disparaging messages to The Atlantic and its journalists on his Truth social platform.&nbsp;
One<a href="https://truthsocial.com/@realDonaldTrump/posts/114180060627046678"> such post </a>read:&nbsp;
"Ashley Parker is not capable of doing a fair and unbiased interview. She is a Radical Left Lunatic, and has been as terrible as is possible for as long as I have known her … Likewise, Michael Scherer has never written a fair story about me, only negative, and virtually always LIES. The Atlantic is doing terribly, losing a fortune, and will hopefully fold up and be gone in the not too distant future. It has absolutely no credibility, and would be far better off, in terms of "journalism," to cease publication," Trump wrote. 
The Interview: Surprisingly, The Atlantic writers reported Trump was "calm, engaged, and eager to persuade" during the interview despite his public hostility toward them.&nbsp;&nbsp;
Trump said that he had thrown public insults toward the writers and publication before the interview to "up the pressure" and help them "sell subscriptions."&nbsp;
Trump also projected a powerful and authoritarian persona, according to The Atlantic.&nbsp;
"I run the country and the world," Trump said, contrasting his first term which he described as a fight to "survive" amidst opposition from the "crooked guys."&nbsp;
The Figures: Though Trump projected a powerful and confident image in the interview, voters overwhelmingly disapprove of the president's first 100 days in office.&nbsp;
The latest CNN/SSRS<a href="https://www.cnn.com/2025/04/27/politics/approval-rating-trump-100-days/index.html"> poll</a> showed a 41% approval rating, the lowest for any president at this stage since at least Eisenhower. Only 22% strongly approve of Trump, while 45% strongly disapprove.&nbsp;
Markets have also reacted negatively during the first 100 days of Trump's second term in office. The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), is down 7.9% since Trump was sworn into office on Jan. 20, marking the second-worst first 100-day performance going back to President Richard Nixon's second term, according to CFRA Research. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/45038430/massive-power-outages-hit-spain-portugal-snarling-travel-investigations-into-cause-underway">Massive Power Outages Hit Spain, Portugal Snarling Travel: Investigations Into Cause Underway</a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

Politics

Global

ETFs

Trump Says 'I Run The Country And The World,' Yet Polls Plummet

Barclays analyst Peter Lawson downgrades SpringWorks Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) from Overweight to Equal-Weight and lowers the price target from $63 to $47.

Downgrades

SWTX

Barclays Downgrades SpringWorks Therapeutics to Equal-Weight, Lowers Price Target to $47

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ATNM#AMEX">ATNM</a>) with a Buy and maintains $4 price target.

Reiteration

ATNM

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

Oppenheimer analyst Chris Kotowski maintains Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) with a Outperform and raises the price target from $91 to $94.

Oppenheimer Maintains Outperform on Citigroup, Raises Price Target to $94

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are trading lower by 3.75% to $274.28 during Monday&#8217;s session. The stock is pulling back amid overall market weakness following last week&#8217;s 24% gain, its best performance of 2025.
What To Know: Investor enthusiasm around Tesla last week was fueled by a mix of favorable policy developments and strategic company initiatives. U.S. Transportation Secretary Sean Duffy unveiled a <a href="https://www.benzinga.com/25/04/45001024/trump-administration-announces-exemptions-for-autonomous-driving-companies-in-the-us-eases-self-driving-crash-report-requirements">new regulatory framework</a> designed to accelerate the development of autonomous vehicles, a move widely viewed as a major boost to Tesla's robotaxi ambitions.
Meanwhile, Tesla launched new promotions to counter <a href="https://www.benzinga.com/tech/25/04/45004433/tesla-rolls-out-free-fsd-transfers-on-all-us-models-including-cybertruck-amid-poor-sales">slowing domestic demand</a>, including free transfers of its Full Self-Driving feature and 0% APR financing on select models. These incentives come as Tesla grapples with a sharp 71% decline in <a href="https://www.benzinga.com/news/earnings/25/04/44937440/tesla-q1-misses-estimates-as-tariff-pressures-weigh-on-outlook-lower-cost-evs-still-on-track">first-quarter profits</a>.
The EV giant also introduced a more affordable Cybertruck variant and reaffirmed plans to release lower-cost models in 2025. Analysts at Piper Sandler and Wedbush <a href="https://www.benzinga.com/25/04/44971783/piper-sandler-puts-400-price-target-on-tesla-it-appears-our-best-case-scenario-has-materialized">remain bullish</a>, maintaining price targets of $400 and $350, respectively, citing Tesla's potential in autonomy and <a href="https://www.benzinga.com/tech/25/04/45002938/tesla-bull-gary-black-says-robotaxi-experiment-in-austin-with-10-20-cars-does-not-warrant-billions-in-valuation-potential">new product rollouts</a>.
Despite some investor skepticism about the immediate impact of its robotaxi initiative, Tesla pressed forward. Challenges like rising insurance costs and public protests were also formally disclosed as risks in a <a href="https://www.benzinga.com/tech/25/04/44974056/tesla-protests-are-now-an-official-risk-factor-for-elon-musks-ev-giant-company-tells-sec-exaggerated-criticism-could-hinder-fundraising-efforts">recent SEC filing</a>.
Read Also: <a href="https://www.benzinga.com/news/25/04/45043857/why-cantor-equity-partners-cep-stock-is-up-200-over-the-past-week">Why Cantor Equity Partners Stock Is Up 200% Over The Past Week</a>
<h2 class="wp-block-heading">How To Buy TSLA Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Tesla&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, TSLA has a 52-week high of $488.54 and a 52-week low of $157.40.

TSLA

Tesla Stock Pulls Back Following Best Week Of 2025: What's Going On?

WIIM

GSHD

Goosehead Insurance shares are trading lower after BMO Capital maintained a Market Perform rating on the stock and lowered its price target from $148 to $142.

Jefferies analyst Paul Zimbardo maintains Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Hold and lowers the price target from $274 to $223.

Jefferies Maintains Hold on Constellation Energy, Lowers Price Target to $223

Needham analyst Mike Matson reiterates InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) from Hold to Hold.

INMD

Needham Reiterates Hold on InModeto Hold

Oppenheimer analyst Rupesh Parikh maintains Church &amp; Dwight Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) with a Outperform and lowers the price target from $120 to $115.

Oppenheimer Maintains Outperform on Church & Dwight Co, Lowers Price Target to $115

Investors ditched their worries last week, and <a href="https://www.benzinga.com/etfs">some ETFs exploited the increased euphoria</a> full tilt.
ETF Weekly Performance Highlights:
VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>):
SMH jumped 13% last week, fueled by a spectacular rally in chip stocks. Investor optimism over AI, cloud computing, and tenacious demand for semiconductors fueled the meteoric surge of this ETF.
Virtus LifeSci Biotech Clinical Trials ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBC#NYSE">BBC</a>): BBC rose 7%, with the biotech industry regaining some much-needed mojo. Investors seemed happy to roll the dice on clinical trial breakthroughs, ignoring the industry&#8217;s typical volatility.
Simplify Volt TSLA Revolution ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TESL#NYSE">TESL</a>): TESL surged 31.2% in its strongest week in months. Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock jumped after <a href="https://www.benzinga.com/markets/25/04/44974342/elon-musks-wealth-skyrockets-by-billions-as-tesla-stock-rallies-after-billionaire-ceo-steps-back-from-doge">Elon Musk promised to dial back his time with the government</a> and shift his focus back to the EV behemoth, music to Tesla shareholders&#8217; ears.
Invesco S&amp;P 500 High Beta ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHB#NYSE">SPHB</a>): SPHB gained 11.5% as risk appetite roared back. High-beta stocks, the market&#8217;s resident drama queens, were once again popular with investors seeking momentum.
iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>): IBIT gained 9.2%, benefiting from Bitcoin&#8217;s recovery and renewed optimism about crypto. Hodl (&#8220;Hold on for dear life&#8221;), it seems, remains a lifestyle choice.
What Happened Last Week
While ETFs led the dance, overall market sentiment also <a href="https://www.benzinga.com/government/regulations/25/04/45022314/wall-street-recovers-dollar-steadies-as-trump-tempers-trade-fight-signals-support-for-powell-this-week-in-markets">received a much-needed dose of adrenaline</a>.
Markets regained their groove as investor anxiety over the U.S.–China trade war eased. The Trump administration signaled the possibility of tariff reductions, and China considered putting some levies on hold, according to reports. Never one to pass up a headline, President Donald Trump assured investors he had no intention of firing Fed Chair Jerome Powell, which eased concerns over central bank autonomy.
The S&amp;P 500 has clawed back almost 80% of its post-April 2 &#8220;Liberation Day&#8221; sell-off. Earlier sell-offs in Treasuries and the dollar also halted, as investors adopted a risk-on sentiment.
But beneath the surface, warning lights continue to flash:
U.S. private sector growth<a href="https://www.benzinga.com/government/regulations/25/04/44952395/us-business-activity-growth-slows-in-april-as-services-suffer-tariff-shock-markets-rally-as-trade-war-cools"> moderated to a 16-month low</a>. Consumer sentiment saw the worst three-month slump since the 1990 recession.
Inflation expectations jumped to levels not seen since &#8220;Eye of the Tiger&#8221; was the chart-topper.
In the stock world, ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) posted a 20% weekly gain on robust earnings, and Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) dropped 15% after scaling back its 2025 outlook. Tesla shares, meanwhile, had their largest weekly jump since November following Musk&#8217;s pledge to spend less time with the Department of Government Efficiency (DOGE) and focus more on making electric vehicles.
What&#8217;s Ahead
Action this week will be paramount, with high-profile earnings from Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>). In addition, look for a data dump: the initial peek at Q1 GDP, the Fed&#8217;s favored inflation gauge for March, and the April jobs report.
Markets may have flown high last week, but this week may be an entire different ball game.
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/04/45039498/sec-approves-proshares-xrp-futures-etfs-xrp-price-surges-ahead-of-launch">SEC Approves ProShares XRP Futures ETFs: XRP Price Surges Ahead Of Launch</a></li>
</ul>
Photo: Aksana Mestnaya/Shutterstock

AAPL

AMZN

IBIT

MSFT

SPHB

TESL

ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On

Janney Montgomery Scott analyst Jason Stewart upgrades ARMOUR Residential REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARR#NYSE">ARR</a>) from Neutral to Buy.

Upgrades

Janney Montgomery Scott Upgrades ARMOUR Residential REIT to Buy

Oppenheimer analyst Chris Kotowski maintains Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) with a Outperform and raises the price target from $50 to $51.

Oppenheimer Maintains Outperform on Bank of America, Raises Price Target to $51

Fermium Research analyst Frank Mitsch upgrades LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) from Hold to Buy and announces $70 price target.

Fermium Research Upgrades LyondellBasell Industries to Buy, Announces $70 Price Target

Oppenheimer analyst Jason Helfstein maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Outperform and lowers the price target from $260 to $220.

Oppenheimer Maintains Outperform on Amazon.com, Lowers Price Target to $220

Press Releases

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of The AZEK Company Inc. - AZEK

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders

Legal

AZEK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of The AZEK Company to James Hardie Industries

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of The AZEK Company Inc.

AZEK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AZEK Company Inc. - AZEK

Comments

AZEK Co

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL